During the past decade, Südharz-Krankenhaus Nordhausen gGmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Südharz-Krankenhaus Nordhausen gGmbH" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Südharz-Krankenhaus Nordhausen gGmbH" are "Chronic Lymphocytic Leukemia" (2 trials), "Head and Neck Cancer" (1 trials), "Larynx Carcinoma" (1 trials), "Sepsis" (1 trials) and "Shock, Septic" (1 trials). Many other conditions were trialed in "Südharz-Krankenhaus Nordhausen gGmbH" in a lesser frequency.

Most popular intervention types in "Südharz-Krankenhaus Nordhausen gGmbH" are "Drug" (4 trials), "Behavioral" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (2 trials), "5-Fluorouracil (TPF) (only until Feb 2009)" (1 trials), "Cetuximab" (1 trials), "Change Management" (1 trials) and "Cisplatin (TP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Südharz-Krankenhaus Nordhausen gGmbH" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Südharz-Krankenhaus Nordhausen gGmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Südharz-Krankenhaus Nordhausen gGmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Südharz-Krankenhaus Nordhausen gGmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".